[go: up one dir, main page]

DE68919114D1 - Undenaturiertes Proteinkonzentrat aus Molke. - Google Patents

Undenaturiertes Proteinkonzentrat aus Molke.

Info

Publication number
DE68919114D1
DE68919114D1 DE68919114T DE68919114T DE68919114D1 DE 68919114 D1 DE68919114 D1 DE 68919114D1 DE 68919114 T DE68919114 T DE 68919114T DE 68919114 T DE68919114 T DE 68919114T DE 68919114 D1 DE68919114 D1 DE 68919114D1
Authority
DE
Germany
Prior art keywords
whey protein
protein concentrate
undenatured whey
undenatured
lactalbumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68919114T
Other languages
English (en)
Other versions
DE68919114T2 (de
Inventor
Phil Prof Gold
Gustavo Bounous
Patricia L Kongshavn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
2458781 CANADA INC., VAUDREUIL, QUEBEC, CA
Original Assignee
Immunotec Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotec Research Corp filed Critical Immunotec Research Corp
Publication of DE68919114D1 publication Critical patent/DE68919114D1/de
Application granted granted Critical
Publication of DE68919114T2 publication Critical patent/DE68919114T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/833—Whey; cheese

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dairy Products (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Luminescent Compositions (AREA)
DE68919114T 1988-04-29 1989-04-28 Undenaturiertes Proteinkonzentrat aus Molke. Expired - Lifetime DE68919114T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18827188A 1988-04-28 1988-04-28
US28997188A 1988-12-23 1988-12-23

Publications (2)

Publication Number Publication Date
DE68919114D1 true DE68919114D1 (de) 1994-12-08
DE68919114T2 DE68919114T2 (de) 1995-05-24

Family

ID=26883894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68919114T Expired - Lifetime DE68919114T2 (de) 1988-04-29 1989-04-28 Undenaturiertes Proteinkonzentrat aus Molke.

Country Status (9)

Country Link
US (2) US5290571A (de)
EP (1) EP0339656B1 (de)
JP (1) JP2510724B2 (de)
AT (1) ATE113474T1 (de)
CA (1) CA1333471C (de)
DE (1) DE68919114T2 (de)
DK (1) DK172782B1 (de)
ES (1) ES2065352T3 (de)
FI (1) FI892006L (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
FR2657013B1 (fr) * 1990-01-18 1992-05-15 Medgenix Group Sa Composition dietetique a base de polypeptides et acides amines.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
ATE278807T1 (de) * 1992-02-19 2004-10-15 New York Health Res Inst Neue anordnungen von oligonukleotiden und ihr nutzen zum sortieren, isolieren, sequenzierung und manipulieren von nukleinsäuren
WO1993025232A1 (en) * 1992-06-16 1993-12-23 Stolle Research And Development Corporation The use of hyperimmune milk to increase longevity
US6027735A (en) * 1992-07-28 2000-02-22 Effem Gmbh Products and processes for gastric cascade and gastrointestinal disorder treatment with same
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
DE4413839C1 (de) * 1994-04-21 1995-10-19 Fritz Koch Pharma Gmbh Dr Med Kombinationspräparat
EP0776214B1 (de) 1994-08-16 1999-07-28 Hemant Sabharwal Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
JP2789554B2 (ja) * 1994-09-26 1998-08-20 全国農業協同組合連合会 免疫活性を有するアルカリ処理ヨーグルト粉末の製造法
US5985275A (en) * 1995-04-12 1999-11-16 New York Blood Center β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
US5670196A (en) * 1995-04-12 1997-09-23 Galagen Inc. Method for microfiltration of milk or colostral whey
US5707678A (en) * 1995-04-12 1998-01-13 Galagen Inc. Method for microfiltration of milk or colostral whey
IL126086A (en) * 1996-03-06 2001-10-31 Belloch Corp I Method for treating liquid materials
IL117505A (en) * 1996-03-15 1999-09-22 Niva Shapira Enriched dairy products
US5952009A (en) * 1996-03-20 1999-09-14 New York Blood Center Methods for preventing the transmission of or treating patients infected with herpesvirus
US5882714A (en) * 1996-04-15 1999-03-16 The Iams Company Queens milk replacer
US5792501A (en) * 1996-04-15 1998-08-11 The Iams Company Queen's milk replacer
US6057367A (en) 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
TW517089B (en) * 1996-09-03 2003-01-11 Res Dev Foundation Assessment of intracellular cysteine and glutathione concentrations
DE19649891C2 (de) * 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
NL1005037C2 (nl) * 1997-01-17 1998-07-20 Nl Zuivelonderzoek Inst Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten.
US5993866A (en) * 1997-09-12 1999-11-30 Shapira; Niva Process of making food products having reduced methionine ratios
US6262019B1 (en) 1998-04-30 2001-07-17 Vit-Immune, L. C. Method of treatment of glutathione deficient mammals
US6667063B2 (en) * 1998-06-10 2003-12-23 Albert Crum Nutritional or therapeutic supplement and method
US6203805B1 (en) 1998-11-10 2001-03-20 Color Access, Inc. Topical compositions containing whey proteins
ATE228779T1 (de) * 1999-01-20 2002-12-15 Nutricia Nv Säuglingsnährpräparat
US6168819B1 (en) * 1999-04-06 2001-01-02 Kraft Foods, Inc. Cappuccino creamer with improved foaming characteristics
JP2003510363A (ja) * 1999-10-04 2003-03-18 カーター、ジョン 医薬組成物及びその使用法
WO2001035765A2 (en) * 1999-11-17 2001-05-25 Tufts University Nutritional supplement systems for populations of women
EP1201137B1 (de) * 2000-10-24 2006-06-07 Campina Melkunie B.V. Peptiden reich an Cystein und/oder Glycin
WO2002069964A1 (en) * 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
CA2470776A1 (en) 2001-12-20 2003-07-03 Eric Simard Malleable protein matrix and uses thereof
US20030166866A1 (en) * 2002-01-28 2003-09-04 Land O' Lakes, Inc. Method of processing a proteinaceous material to recover K-casein macropeptide and polymers of a-lactalbumin and B-lactoglobulin
DE60238663D1 (de) * 2002-04-05 2011-02-03 Nestle Sa Zusammensetzungen und Verfahren zur Verbesserung von Lipidassimilation in Haustieren
US6592908B1 (en) 2002-09-23 2003-07-15 Albert Crum Nutritional or therapeutic compositions
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
US20050112176A1 (en) * 2002-12-20 2005-05-26 Dopson Minter H. Nutritional supplement composition and method
US20050112177A1 (en) * 2002-12-20 2005-05-26 Dopson Minter H. Nutritional supplement composition and method
WO2005062739A2 (en) * 2003-05-23 2005-07-14 Ott David M S-allylmercaptocysteine prodrugs and methods of treatment
WO2005110124A1 (en) * 2004-04-15 2005-11-24 Abbott Laboratories Composition and methods for nutritional management of patients with hepatic disease
US8217084B2 (en) * 2004-05-24 2012-07-10 Allium Vitalis Incorporated Medicinal products incorporating bound organosulfur groups
EP2177229A3 (de) * 2004-09-29 2010-11-03 Asama Chemical Co., Ltd. Funktionelle Zusammensetzung oder Nahrungsmittel enthaltend Molkeprotein, Antikörper aus der Milch oder Antikörper
US20060115468A1 (en) * 2004-11-26 2006-06-01 Kara Morrison Dietary supplement for treating and preventing gastrointestinal disorders
WO2006127918A2 (en) * 2005-05-24 2006-11-30 Ott David M Personal care and medicinal products incorporating bound organosulfur groups
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
US20100069288A1 (en) * 2008-09-12 2010-03-18 Wulf Droge Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
EP2165713B1 (de) * 2008-09-19 2012-11-14 Nestec S.A. Molke und Verbesserung der Thymusfunktion
US8367354B2 (en) 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8350006B2 (en) 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
US20180002374A1 (en) * 2013-03-14 2018-01-04 Green Recovery Technologies, LLC Non-Denatured Proteins Derived From a Biomass Source
CA3038048A1 (en) 2016-09-23 2018-03-29 Immunotec Inc. Compositions for restoring gene expression in neuropsychiatric or neurodegenerative disorders
CA2970699A1 (en) 2017-06-14 2018-12-14 Elizabeth E. Ignowski Compositions for increasing resilience to traumatic brain injury
US11944649B2 (en) 2017-07-31 2024-04-02 Immunotec Inc. Compositions and methods for treatment of autism spectrum disorder
US20240237673A1 (en) * 2023-01-13 2024-07-18 Leprino Foods Company Denatured milk proteins, methods of making, and protein fortified foods

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH556143A (fr) * 1972-09-11 1974-11-29 Nestle Sa Procede de preparation d'une fraction soluble des proteines du petit lait.
US4043990A (en) * 1974-03-20 1977-08-23 Stauffer Chemical Company Process for the recovery of whey protein having improved solution clarity using polyphosphates
FR2296428A1 (fr) * 1975-01-03 1976-07-30 Baignes Ste Radegonde Laiterie Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte
GB1495940A (en) * 1975-02-18 1977-12-21 Grindstedvaerket As Anti-cancer active whey fraction
US4112123A (en) * 1976-07-21 1978-09-05 Beatrice Foods Co. Nutritionally balanced single food composition and method of production
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
US4497836A (en) * 1982-08-06 1985-02-05 Dairy Technology Ltd. Modified whey product and process including ultrafiltration and demineralization
IE55320B1 (en) * 1983-06-16 1990-08-01 Farley Health Products Infant foods
NL8403433A (nl) * 1984-11-09 1986-06-02 Holland Melkunie Voedingssuppletiepreparaat op basis van melkbestanddelen.
US4834974A (en) * 1986-01-13 1989-05-30 Protein Technologies, Inc. Immunologically active whey fraction and recovery process
US4710489A (en) * 1985-04-22 1987-12-01 Cornell Research Foundation, Inc. Glutathione delivery system
DE3523342A1 (de) * 1985-06-29 1987-01-02 Reinhardt Thyzel Vorrichtung zur laserchirurgie und insbesondere zur keratomie der cornea (i)
JP2623342B2 (ja) * 1989-06-01 1997-06-25 雪印乳業株式会社 脱塩乳類の製造方法

Also Published As

Publication number Publication date
DK172782B1 (da) 1999-07-12
EP0339656B1 (de) 1994-11-02
US5451412A (en) 1995-09-19
EP0339656A3 (en) 1990-06-20
JPH02152929A (ja) 1990-06-12
DK207489D0 (da) 1989-04-28
ATE113474T1 (de) 1994-11-15
EP0339656A2 (de) 1989-11-02
ES2065352T3 (es) 1995-02-16
CA1333471C (en) 1994-12-13
DE68919114T2 (de) 1995-05-24
JP2510724B2 (ja) 1996-06-26
FI892006L (fi) 1989-10-30
FI892006A0 (fi) 1989-04-27
DK207489A (da) 1989-10-30
US5290571A (en) 1994-03-01

Similar Documents

Publication Publication Date Title
DE68919114D1 (de) Undenaturiertes Proteinkonzentrat aus Molke.
FI863586L (fi) Foerfarande foer framstaellning av sojaproteinisolat med laog fytathalt.
FR2634104B1 (fr) Hydrolysat partiel de proteines de lactoserum, procede enzymatique de preparation de cet hydrolysat, et aliment lacte dietetique hypoallergenique le contenant
AU573523B2 (en) Functional human urokinase proteins
ATE91714T1 (de) Transformation von trichoderma.
ATE163013T1 (de) Alveolare oberflächenaktive proteine
DK0485663T3 (da) Spiselig sammensætning af denaturerede valleproteiner
AU571552B2 (en) Protein concentrates from animal blood
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
ATE43500T1 (de) Herstellung von antikoerpern.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
AU7784687A (en) Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same
FR2296428A1 (fr) Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte
IE35558L (en) Separating protein from whey.
DK0714910T3 (da) Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud
DK199284A (da) Diaetetisk eller terapeutisk praeparat
NZ331212A (en) Ectoparasite (flea) saliva proteins and their use screening for dermatological allergy
DE68913386D1 (de) Selektive enzymatische Zersetzung von beta-Lactoglobulin in Molkeeiweiss von Kuhmilch.
Hamazaki et al. Comparative studies of human, equine, porcine and bovine erythrocyte membrane sialoglycoproteins
ES2164876T3 (es) Procedimiento para la fabricacion de alimentos dieteticos para lactantes y niños prematuros y alimentos dieteticos.
ATE90569T1 (de) Praeparat mit antikoerperaktivitaet und breitem wirkungsspektrum, daraus bestehende oder diese enthaltende mittel und deren verwendung zur behandlung von bakteriell oder toxin-bedingten erkrankungen und zur bekaempfung von protozoen.
Esievo Variations in hematologic parameters among high-producing dairy cattle on high and low protein diets; Effects of protein intake and stage of lactation on hematological constituents and activities of red blood cell enzymes of high-producing dairy cattle; Hemoglobin-binding proteins (Haptoglobin-Hp) in normal healthy dairy cattle sera
EP0219839A3 (de) Derivat des Interleukin-2, seine Herstellung und Verwendung
FI873546L (fi) Foerfarande foer framstaellning av vaermeresistanta, icke-bittra, vattenloesliga peptidprodukter, produkten framstaelld med foerfarandet och naeringsmedel, foerfriskningsmedel och dietkoster innehaollande produkten.
MX9203722A (es) Ultrapurificacion del factor ix y otras proteinas dependientes de vitamina k.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: 2458781 CANADA INC., VAUDREUIL, QUEBEC, CA